Arbutus Biopharma Corporation ABUS Price / sales
Price / sales at other companies
Other financials
Where this comes from
Calculated from Arbutus Biopharma Corporation’s reported figures.
Based on the most recent quarter.
The official record: Arbutus Biopharma Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arbutus Biopharma Corporation's price / sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arbutus Biopharma Corporation's price / sales?
- Arbutus Biopharma Corporation (ABUS) reported price / sales of 4.6× in Q1 2026.
- How has Arbutus Biopharma Corporation's price / sales changed year-over-year?
- Arbutus Biopharma Corporation's price / sales decreased by 95.6% year-over-year, from 104.4× to 4.6×.
- What is the long-term trend for Arbutus Biopharma Corporation's price / sales?
- Over 5 years (2020 to 2025), Arbutus Biopharma Corporation's price / sales has grown at a -1.1% compound annual growth rate (CAGR), from 69.5× to 65.7×.
- What does price / sales mean?
- Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.